1. Home
  2. AFYA vs RCUS Comparison

AFYA vs RCUS Comparison

Compare AFYA & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AFYA
  • RCUS
  • Stock Information
  • Founded
  • AFYA 1999
  • RCUS 2015
  • Country
  • AFYA Brazil
  • RCUS United States
  • Employees
  • AFYA N/A
  • RCUS N/A
  • Industry
  • AFYA Other Consumer Services
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • AFYA Real Estate
  • RCUS Health Care
  • Exchange
  • AFYA Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • AFYA 1.5B
  • RCUS 1.2B
  • IPO Year
  • AFYA 2019
  • RCUS 2018
  • Fundamental
  • Price
  • AFYA $17.35
  • RCUS $11.07
  • Analyst Decision
  • AFYA Sell
  • RCUS Buy
  • Analyst Count
  • AFYA 5
  • RCUS 11
  • Target Price
  • AFYA $18.00
  • RCUS $31.11
  • AVG Volume (30 Days)
  • AFYA 110.2K
  • RCUS 1.1M
  • Earning Date
  • AFYA 03-13-2025
  • RCUS 02-25-2025
  • Dividend Yield
  • AFYA N/A
  • RCUS N/A
  • EPS Growth
  • AFYA 62.61
  • RCUS N/A
  • EPS
  • AFYA 1.17
  • RCUS N/A
  • Revenue
  • AFYA $584,951,886.00
  • RCUS $263,000,000.00
  • Revenue This Year
  • AFYA $17.42
  • RCUS $127.65
  • Revenue Next Year
  • AFYA $12.85
  • RCUS N/A
  • P/E Ratio
  • AFYA $14.82
  • RCUS N/A
  • Revenue Growth
  • AFYA 16.67
  • RCUS 119.17
  • 52 Week Low
  • AFYA $14.52
  • RCUS $10.63
  • 52 Week High
  • AFYA $22.24
  • RCUS $20.31
  • Technical
  • Relative Strength Index (RSI)
  • AFYA 59.58
  • RCUS 34.34
  • Support Level
  • AFYA $16.55
  • RCUS $10.63
  • Resistance Level
  • AFYA $18.05
  • RCUS $13.49
  • Average True Range (ATR)
  • AFYA 0.43
  • RCUS 0.77
  • MACD
  • AFYA 0.08
  • RCUS -0.13
  • Stochastic Oscillator
  • AFYA 70.71
  • RCUS 13.88

About AFYA Afya Limited

Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergrad provides educational services through undergraduate courses related to medicine, other health sciences, and other undergraduate programs, Continuing Education provides specialization programs and graduate courses in medicine; and Digital Services provides content and technology for medical education, clinical decisions software, practice management tools (that encompass electronic medical records, telemedicine, and digital prescription, and provides access, demand and efficiency for the healthcare players.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: